Search Results

EISA in Tandem with ICD to Form In Situ Nanofiber Vaccine for Enhanced Tumor Radioimmunotherapy.

• Authors : Luo H; Key Laboratory of Radiopharmacokinetics for Innovative Drugs, Chinese Academy of Medical Sciences, Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine, Institute of Radiation Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300192, P. R. China.; Cao H

Subjects: Nanofibers* ; Neoplasms*/Neoplasms*/Neoplasms*/radiotherapy ; Vaccines*

• Source: Advanced healthcare materials [Adv Healthc Mater] 2023 Oct; Vol. 12 (27), pp. e2301083. Date of Electronic Publication: 2023 Jun 20.Publisher: Wiley-VCH Country of Publication: Germany NLM ID: 101581613 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2192-2659

Record details

Vaccines to Control Salmonella in Poultry.

• Authors : Curtiss R; College of Veterinary Medicine, University of Florida, Gainesville, Florida, .

Subjects: Poultry Diseases*/Poultry Diseases*/Poultry Diseases*/prevention & control ; Salmonella enterica* ; Vaccines*

• Source: Avian diseases [Avian Dis] 2024 Jan; Vol. 67 (4), pp. 427-440.Publisher: American Association Of Avian Pathologists Country of Publication: United States NLM ID: 0370617 Publication Model: Print Cited Medium:

Record details

Genetic variability and mutation of Epstein‒Barr virus (EBV)-encoded LMP-1 and BHRF-1 genes in EBV-infected patients: identification of precise targets for development of personalized EBV vaccines.

• Authors : Wang Y; Forensic Center of Justice, Zhongnan Hospital of Wuhan University, Wuhan, China.; Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China.

Subjects: Epstein-Barr Virus Infections*/Epstein-Barr Virus Infections*/Epstein-Barr Virus Infections*/genetics ; Epstein-Barr Virus Infections*/Epstein-Barr Virus Infections*/Epstein-Barr Virus Infections*/pathology ; Vaccines*

• Source: Virus genes [Virus Genes] 2023 Aug; Vol. 59 (4), pp. 541-553. Date of Electronic Publication: 2023 May 27.Publisher: Kluwer Academic Country of Publication: United States NLM ID: 8803967 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Nanodiamonds: A Cutting-Edge Approach to Enhancing Biomedical Therapies and Diagnostics in Biosensing.

• Authors : Hyder A; National Centre of Excellence in Analytical Chemistry, University of Sindh, Jamshoro, 76080, Pakistan.; Ali A

Subjects: Nanodiamonds*/Nanodiamonds*/Nanodiamonds*/chemistry ; Communicable Diseases* ; Vaccines*

• Source: Chemical record (New York, N.Y.) [Chem Rec] 2024 Apr; Vol. 24 (4), pp. e202400006. Date of Electronic Publication: 2024 Mar 26.Publisher: Wiley Country of Publication: United States NLM ID: 101085550 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Agricola

Record details

Targeting fibroblast activation protein (FAP): advances in CAR-T cell, antibody, and vaccine in cancer immunotherapy.

• Authors : Shahvali S; Nanotechnology Research Center, Institute of Pharmaceutical Technology, Mashhad University of Medical Sciences, Mashhad, Iran.; Rahiman N

Subjects: Receptors, Chimeric Antigen*/Receptors, Chimeric Antigen*/Receptors, Chimeric Antigen*/metabolism ; Neoplasms*/Neoplasms*/Neoplasms*/pathology ; Vaccines*

• Source: Drug delivery and translational research [Drug Deliv Transl Res] 2023 Jul; Vol. 13 (7), pp. 2041-2056. Date of Electronic Publication: 2023 Feb 25.Publisher: Springer Country of Publication: United States NLM ID: 101540061 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Immunostimulatory effects of Hsp70 fragments and Hsp27 in design of novel HIV-1 vaccine formulations.

• Authors : Milani A; Department of Hepatitis and AIDS, Pasteur Institute of Iran, Tehran, Iran.; Akbari E

Subjects: HIV-1*/HIV-1*/HIV-1*/genetics ; HIV Infections*/HIV Infections*/HIV Infections*/prevention & control ; Vaccines*

• Source: HIV medicine [HIV Med] 2024 Feb; Vol. 25 (2), pp. 276-290. Date of Electronic Publication: 2023 Nov 07.Publisher: Wiley Country of Publication: England NLM ID: 100897392 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-1293

Record details

Construction and Application of Orthogonal T7 Expression System in Eukaryote: An Overview.

• Authors : Wang W; College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, 100029, P. R. China.; An X

Subjects: Eukaryota*/Eukaryota*/Eukaryota*/genetics ; Eukaryota*/Eukaryota*/Eukaryota*/metabolism ; Vaccines*

• Source: Advanced biology [Adv Biol (Weinh)] 2023 Feb; Vol. 7 (2), pp. e2200218. Date of Electronic Publication: 2022 Dec 04.Publisher: Wiley-VCH GmbH Country of Publication: Germany NLM ID: 101775319 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Chromosome-scale Echinococcus granulosus (genotype G1) genome reveals the Eg95 gene family and conservation of the EG95-vaccine molecule.

• Authors : Korhonen PK; Department of Veterinary Biosciences, Melbourne Veterinary School, Faculty of Veterinary and Agricultural Sciences, The University of Melbourne, Parkville, VIC, 3010, Australia.; Kinkar L

Subjects: Echinococcosis*/Echinococcosis*/Echinococcosis*/genetics ; Echinococcosis*/Echinococcosis*/Echinococcosis*/prevention & control ; Echinococcus granulosus*/Echinococcus granulosus*/Echinococcus granulosus*/genetics

• Source: Communications biology [Commun Biol] 2022 Mar 03; Vol. 5 (1), pp. 199. Date of Electronic Publication: 2022 Mar 03.Publisher: Nature Publishing Group UK Country of Publication: England NLM ID: 101719179 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

A conserved N protein nano-vaccine of COVID-19 exerts potent and cross-reactive humoral and cellular immune responses in mice.

• Authors : Li B; Department of Biotechnology, School of Life Sciences and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou, China.; Zhang J

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; Vaccines* ; Middle East Respiratory Syndrome Coronavirus*SARS-CoV-2 variants

• Source: Journal of medical virology [J Med Virol] 2023 Sep; Vol. 95 (9), pp. e29115.Publisher: Wiley-Liss Country of Publication: United States NLM ID: 7705876 Publication Model: Print Cited Medium: Internet ISSN: 1096-9071

Record details